Average Co-Inventor Count = 5.62
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Minnesota (14 from 2,313 patents)
2. The United States of America, as Represented by the Secretary, Department of Health and Human Services (11 from 3,540 patents)
3. Intima Bioscience, Inc. (11 from 13 patents)
4. B-Mogen Biotechnologies, Inc. (4 from 4 patents)
5. Rd Systems (2 from 6 patents)
6. Other (1 from 832,912 patents)
21 patents:
1. 12281327 - Lymphohematopoietic engineering using CAS9 base editors
2. 12097220 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
3. 12037611 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
4. 12030953 - Chimeric antigen receptors, compositions, and methods
5. 11925664 - Intracellular genomic transplant and methods of therapy
6. 11903966 - Intracellular genomic transplant and methods of therapy
7. 11760983 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
8. 11642374 - Intracellular genomic transplant and methods of therapy
9. 11642375 - Intracellular genomic transplant and methods of therapy
10. 11583556 - Modified cells and methods of therapy
11. 11278570 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
12. 11266692 - Intracellular genomic transplant and methods of therapy
13. 11162084 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
14. 11154574 - Tumor infiltrating lymphocytes and methods of therapy
15. 11147837 - Modified cells and methods of therapy